Back to search results

Medtronic Product Surveillance Registry

This study, called the Product Surveillance Registry, is looking at the safety and effectiveness of Medtronic medical products that are already available on the market. It aims to gather information to help patients, hospitals, doctors, and others. You could join if you have or are going to receive a Medtronic product, and you provide written permission. The study will measure how safe and effective these products are every 6-12 months, depending on the specific treatment. The current status of this study is unclear, but it plans to include up to 100,000 people.

Study design
This is an observational study, meaning researchers will watch and collect information without giving specific treatments. It plans to include a large number of participants, up to 100,000 people.
What's involved
You would need to provide written authorization or consent. You must also have received or be planning to receive a Medtronic product.
Compensation
Not stated in the trial record.
Follow-up
The safety and effectiveness of the products will be measured every 6-12 months, depending on the therapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01524276

Product Surveillance Registry

Recruiting
Not specifiedAll AgesObservational
Medtronic
~100,000 participants
Updated 2026-08-18 on ClinicalTrials.gov

At a glance

Recruiting sites
380 of 400 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety and Effectiveness of Market Released products
Measured over Every 6-12 months (Therapy-dependent)

Conditions

Cardiac Rhythm Disorders
Urological Disorders
Neurological Disorders
Cardiovascular Disorders
Digestive Disorders
Intracranial Aneurysm
Mechanical Circulatory Support
Respiratory Therapy
Aortic, Peripheral Vascular and Venous Disorders
Minimally Invasive Surgical Procedures
Diagnostic Techniques and Procedures
Surgical Procedures, Operative
Renal Insufficiency
Neurovascular
Coronary Artery Disease
Ear, Nose and Throat Disorder

Explore related trials

Aortic, Peripheral Vascular and Venous DisordersCardiac Rhythm DisordersCardiovascular DisorderCoronary Artery DiseaseDigestive System DisorderEar, nose and throat disorderIntracranial AneurysmMechanical Circulatory SupportNervous System DisorderNeurovascularRenal FailureRespiratory TherapyUrinary System Disorder

Where it's being run

400 sites across 93 states
Japan30
Germany26
France25
Italy18
United Kingdom17
Spain16
New York14
South Korea13

Who to contact

Medtronic Product Surveillance Registry
[email protected]
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
Patient has or is intended to receive or be treated with an eligible Medtronic product
Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Exclusion

Patient who is, or will be, inaccessible for follow-up
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

What this trial measures

  • Safety and Effectiveness of Market Released productsEvery 6-12 months (Therapy-dependent)